Abstract
BACKGROUND AND PURPOSE: Thrombus permeability assessed on conventional CTA is associated with neurologic outcome in patients with acute ischemic stroke. We aimed to investigate whether dynamic CTA can improve the accuracy of thrombus permeability assessment and its predictive value for outcome.
MATERIALS AND METHODS: We reviewed consecutive patients with acute ischemic stroke who had occlusion of the M1 segment of the middle artery cerebral artery and underwent pretreatment perfusion CT. Thrombus permeability, determined by thrombus attenuation increase (TAI), was assessed on 26-phase dynamic CTA derived from perfusion CT. TAImax was defined as the maximum TAI among phases; TAIpeak, as TAI of peak arterial phase; TAIcon, as TAI on phase 13. Good outcome was defined as a 3-month mRS score of ≤2.
RESULTS: One hundred four patients were enrolled in the final analysis. The median TAImax, TAIpeak, and TAIcon were 30.1 HU (interquartile range, 13.0–50.2 HU), 9.5 HU (interquartile range, −1.6–28.7 HU), and 6.6 HU (interquartile range, −5.1–24.4 HU), respectively. Multivariable regression analyses showed that TAImax (OR = 1.027; 95% CI, 1.007–1.048; P = .008), TAIpeak (OR = 1.029; 95% CI, 1.005–1.054; P = .020), and TAIcon (OR = 1.026; 95% CI, 1.002–1.051; P = .037) were independently associated with good outcome. The areas under the ROC curve of TAImax, TAIpeak, and TAIcon in predicting good outcome were 0.734, 0.701, and 0.658, respectively.
CONCLUSIONS: Thrombus permeability assessed on dynamic CTA could be a better predictor of outcome after reperfusion therapy than that assessed on conventional single-phase CTA.
ABBREVIATIONS:
- AIS
- acute ischemic stroke
- AUC
- area under the curve
- IQR
- interquartile range
- PH
- parenchymal hemorrhage
- ONT
- onset to intravenous thrombolysis
- ROC
- receiver operating characteristic
- TAI
- thrombus attenuation increase
- TAIcon
- TAI on phase 13
- TAImax
- the maximum TAI among phases
- TAIpeak
- TAI of peak arterial phase
Footnotes
Z. Chen and F. Shi contributed equally to this work.
Disclosures: Zhicai Chen—RELATED: Grant: National Natural Science Foundation of China (81601017) and Zhejiang Provincial Natural Science Foundation of China (LQ16H090003).* Min Lou—RELATED: Grant: National Natural Science Foundation of China (81622017 and 81471170), Comments: National Natural Science Foundation of China (81622017 and 81471170), the National Key Research and Development Program of China (2016YFC1301500), and Fundamental Research Funds for the Central Universities (2017XZZX002-09).* *Money paid to the institution.
This study was supported by the National Key Research and Development Program of China (2016YFC1301500), the National Natural Science Foundation of China (81622017, 81471170, and 81601017), Fundamental Research Funds for the Central Universities (2017XZZX002-09), and Zhejiang Provincial Natural Science Foundation (LQ16H090003).
- © 2018 by American Journal of Neuroradiology
Indicates open access to non-subscribers at www.ajnr.org